目錄:杭州斯達(dá)特生物科技有限公司>>蛋白>>藥物靶點(diǎn)和Fc受體>> UA010935CD300g/Nepmucin/CLM9 Fc Chimera Protein, Mouse
參考價(jià) | ¥ 2600 |
參考價(jià) | ¥ 2600 |
更新時(shí)間:2025-07-16 21:31:14瀏覽次數(shù):49評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,謝謝!
Nepmucin/CLM-9 is an Ig domain-containing sialomucin that is expressed in vascular endothelial cells. Our studies demonstrate that, similar to CD31, nepmucin is localized at interendothelial junctions and vesicle-like structures along the cell border, where it undergoes intracellular recycling. Functional analyses reveal that nepmucin mediates both homotypic and heterotypic cell adhesion through its Ig domain. Endothelial cells expressing nepmucin exhibit enhanced lymphocyte transendothelial migration (TEM), which can be inhibited by anti-nepmucin monoclonal antibodies (mAbs) that block either homophilic or heterophilic binding. Notably, mAbs that inhibit homophilic binding are able to block TEM without affecting lymphocyte adhesion. These findings suggest that endothelial nepmucin facilitates lymphocyte TEM through multiple adhesion pathways.
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)